Speakers

Andrew Pierce

Vice President - Translational Biology

Crescendo Biologics

Christiane Amendt

Global Head - Translational In Vivo Pharmacology, Translational Innovation Platform Oncology

Merck KGaA

Sonya Chapman

Senior PK/PD Project Leader

Eli Lilly and Company

Anthony Letai

Professor of Medicine

Dana Faber cancer institute

Chiara Ambrogio

Assistant Professor MBC (Molecular Biotechnology Centre)

University of Turin

Pelin Candarlioglu

Investigator - Complex in Vitro Models

GSK

Samantha Boyle

Senior Scientist

Crescendo Biologics

David Barbie

Associate Director

Dana Faber cancer institute

Gabriela Kramer-Marek

Team Leader, Preclinical Molecular Imaging

Institute of Cancer Research

Sebastian Bunk

Senior Director Immunology, Head of TCR Engineering & Bispecifics

Immatics

Nicola Ferrari

Research Associate- Translational R&D

Astex Pharmaceuticals

Ludovic Bourré

Senior Director Scientific Engagement

Crown Bioscience

Kader Thiam

Vice President of Transgenic Technologies

genOway

Nikolaus Krall

CEO

Allcyte

Chris Armstrong

CEO

Overwatch Research

Jean Viallet

Chief Executive Officer

INOVOTION

Holger Weber

Head of In Vivo Pharmacology

Reaction Biology Europe GmbH

Tseten Jamling

Vice President of Research & Development

Hera Labs Inc

Maryland Franklin

Executive Director Scientific Development

Covance

Loreley Calvet

Laboratory Head Drug Discovery & Preclinical Development

Sanofi-Oncology

Anna Erkstam

Chief Operating Officer

BioReperia

Sukhvinder Sidhu

Global Head of Pharmacology

Sanofi

Suso Platero

Head of Biomarker Solution Center & Global Leader - Precision Medicine

Covance